Report Detail
Global (United States, European Union and China) Pregabalin Market Research Report 2019-2025
- RnM3659567 |
- 09 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.
In 2019, the market size of Pregabalin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pregabalin.
This report studies the global market size of Pregabalin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pregabalin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer Inc.
Torrent Pharmaceuticals Ltd.
Lupin Limited
Zydus Cadila Healthcare Ltd.
Cipla Limited
Genesis Remedies
Sanofi
Medley Pharmaceuticals Limited
Genesis Biotec Inc.
Biomax
Market Segment by Product Type
Epilepsy
Neuropathic Pain
Fibromyalgia
Generalized Anxiety Disorder
Market Segment by Application
Research Institutes
Pharmaceutical Companies
Others (Hospitals and Clinics)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Pregabalin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pregabalin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Pregabalin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Pregabalin Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Epilepsy
- 1.3.3 Neuropathic Pain
- 1.3.4 Fibromyalgia
- 1.3.5 Generalized Anxiety Disorder
- 1.4 Market Segment by Application
- 1.4.1 Global Pregabalin Market Share by Application (2019-2025)
- 1.4.2 Research Institutes
- 1.4.3 Pharmaceutical Companies
- 1.4.4 Others (Hospitals and Clinics)
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Pregabalin Market Size
- 2.1.1 Global Pregabalin Revenue 2014-2025
- 2.1.2 Global Pregabalin Sales 2014-2025
- 2.2 Pregabalin Growth Rate by Regions
- 2.2.1 Global Pregabalin Sales by Regions 2014-2019
- 2.2.2 Global Pregabalin Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Pregabalin Sales by Manufacturers
- 3.1.1 Pregabalin Sales by Manufacturers 2014-2019
- 3.1.2 Pregabalin Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Pregabalin Revenue by Manufacturers (2014-2019)
- 3.2.2 Pregabalin Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Pregabalin Market Concentration Ratio (CR5 and HHI)
- 3.3 Pregabalin Price by Manufacturers
- 3.4 Key Manufacturers Pregabalin Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Pregabalin Market
- 3.6 Key Manufacturers Pregabalin Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Epilepsy Sales and Revenue (2014-2019)
- 4.1.2 Neuropathic Pain Sales and Revenue (2014-2019)
- 4.1.3 Fibromyalgia Sales and Revenue (2014-2019)
- 4.1.4 Generalized Anxiety Disorder Sales and Revenue (2014-2019)
- 4.2 Global Pregabalin Sales Market Share by Type
- 4.3 Global Pregabalin Revenue Market Share by Type
- 4.4 Pregabalin Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Pregabalin Sales by Application
6 United States
- 6.1 United States Pregabalin Breakdown Data by Company
- 6.2 United States Pregabalin Breakdown Data by Type
- 6.3 United States Pregabalin Breakdown Data by Application
7 European Union
- 7.1 European Union Pregabalin Breakdown Data by Company
- 7.2 European Union Pregabalin Breakdown Data by Type
- 7.3 European Union Pregabalin Breakdown Data by Application
8 China
- 8.1 China Pregabalin Breakdown Data by Company
- 8.2 China Pregabalin Breakdown Data by Type
- 8.3 China Pregabalin Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Pregabalin Breakdown Data by Company
- 9.2 Rest of World Pregabalin Breakdown Data by Type
- 9.3 Rest of World Pregabalin Breakdown Data by Application
- 9.4 Rest of World Pregabalin Breakdown Data by Countries
- 9.4.1 Rest of World Pregabalin Sales by Countries
- 9.4.2 Rest of World Pregabalin Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer Inc.
- 10.1.1 Pfizer Inc. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Pregabalin
- 10.1.4 Pregabalin Product Introduction
- 10.1.5 Pfizer Inc. Recent Development
- 10.2 Torrent Pharmaceuticals Ltd.
- 10.2.1 Torrent Pharmaceuticals Ltd. Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Pregabalin
- 10.2.4 Pregabalin Product Introduction
- 10.2.5 Torrent Pharmaceuticals Ltd. Recent Development
- 10.3 Lupin Limited
- 10.3.1 Lupin Limited Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Pregabalin
- 10.3.4 Pregabalin Product Introduction
- 10.3.5 Lupin Limited Recent Development
- 10.4 Zydus Cadila Healthcare Ltd.
- 10.4.1 Zydus Cadila Healthcare Ltd. Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Pregabalin
- 10.4.4 Pregabalin Product Introduction
- 10.4.5 Zydus Cadila Healthcare Ltd. Recent Development
- 10.5 Cipla Limited
- 10.5.1 Cipla Limited Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Pregabalin
- 10.5.4 Pregabalin Product Introduction
- 10.5.5 Cipla Limited Recent Development
- 10.6 Genesis Remedies
- 10.6.1 Genesis Remedies Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Pregabalin
- 10.6.4 Pregabalin Product Introduction
- 10.6.5 Genesis Remedies Recent Development
- 10.7 Sanofi
- 10.7.1 Sanofi Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Pregabalin
- 10.7.4 Pregabalin Product Introduction
- 10.7.5 Sanofi Recent Development
- 10.8 Medley Pharmaceuticals Limited
- 10.8.1 Medley Pharmaceuticals Limited Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Pregabalin
- 10.8.4 Pregabalin Product Introduction
- 10.8.5 Medley Pharmaceuticals Limited Recent Development
- 10.9 Genesis Biotec Inc.
- 10.9.1 Genesis Biotec Inc. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Pregabalin
- 10.9.4 Pregabalin Product Introduction
- 10.9.5 Genesis Biotec Inc. Recent Development
- 10.10 Biomax
- 10.10.1 Biomax Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Pregabalin
- 10.10.4 Pregabalin Product Introduction
- 10.10.5 Biomax Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Pregabalin Sales Channels
- 11.2.2 Pregabalin Distributors
- 11.3 Pregabalin Customers
12 Market Forecast
- 12.1 Global Pregabalin Sales and Revenue Forecast 2019-2025
- 12.2 Global Pregabalin Sales Forecast by Type
- 12.3 Global Pregabalin Sales Forecast by Application
- 12.4 Pregabalin Forecast by Regions
- 12.4.1 Global Pregabalin Sales Forecast by Regions 2019-2025
- 12.4.2 Global Pregabalin Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Pregabalin . Industry analysis & Market Report on Pregabalin is a syndicated market report, published as Global (United States, European Union and China) Pregabalin Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Pregabalin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
